Voluntary Chapter 11 Commenced to Finalize Consensual Go-Forward Plan for Amyris Core Business
$190 Million Financing Commitment from Foris Ventures to Support Day-to-Day Operations
EMERYVILLE,.
EMERYVILLE, Calif., June 26, 2023 /PRNewswire/ Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world s transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty.
/PRNewswire/ Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world s transition to sustainable consumption through.
EMERYVILLE, Calif., May 19, 2023 Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world s transition to sustainable.
/PRNewswire/ Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world s transition to sustainable consumption through.